Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,266Revenue (TTM) $M99.4Net Margin (%)-168.3Altman Z-Score30.3
Enterprise Value $M1,960EPS (TTM) $-1.6Operating Margin %-170.1Piotroski F-Score5
P/E(ttm)--Beneish M-Score-1.9Pre-tax Margin (%)-168.3Higher ROA y-yY
Price/Book6.610-y EBITDA Growth Rate %18.6Quick Ratio10.7Cash flow > EarningsY
Price/Sales20.95-y EBITDA Growth Rate %24.5Current Ratio10.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-47.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-53.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M111ROIC % (ttm)-579.0Gross Margin Increase y-yY

Gurus Latest Trades with EXAS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

EXAS is held by these investors:

EXAS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LIDGARD GRAHAM PETERChief Science Officer 2017-03-13Sell2,945$21.16-3.59view
COWARD D SCOTTSVP and General Counsel 2017-03-13Sell1,983$21.16-3.59view
Conroy Kevin TPresident and CEO 2017-03-13Sell12,059$21.16-3.59view
ARORA MANEESHCOO 2017-03-13Sell5,574$21.16-3.59view
LIDGARD GRAHAM PETERChief Science Officer 2017-02-27Sell8,668$21.51-5.16view
COWARD D SCOTTSVP and General Counsel 2017-02-27Sell7,046$21.48-5.03view
Conroy Kevin TPresident and CEO 2017-02-27Sell27,134$21.51-5.16view
ARORA MANEESHCOO 2017-02-27Sell11,114$21.5-5.12view
COWARD D SCOTTSVP and General Counsel 2017-01-03Sell1,535$13.6149.89view
THOMPSON DAVIDDirector 2016-12-14Buy10,000$13.8447.4view

Press Releases about EXAS :

Quarterly/Annual Reports about EXAS:

News about EXAS:

Articles On GuruFocus.com
Whitney Tilson's Robin Hood Conference Presentation Nov 19 2015 
Why I'm Short Exact Sciences - Whitney Tilson Presentation Feb 24 2015 
Weekly CEO Sells Highlight: Exact Sciences Corp Zayo Group Holdings Inc, Western Alliance Bancorp, a Oct 27 2014 
Meridian Funds Comments on Exact Sciences Corp Jun 20 2014 
Weekly CEO Buys Highlight: BFS, FL, BGC, AMCF, and EXAS Nov 28 2010 
EXACT Sciences Corp. (EXAS) CEO Kevin T Conroy buys 6,000 Shares Nov 23 2010 
EXACT Sciences Corp. (EXAS) CFO Maneesh Arora buys 2,500 Shares Aug 20 2010 
Weekly CFO Buys Highlight: Heska Corp., Apollo Investment Corp., EXACT Sciences Corp., Innospec Inc. Feb 28 2010 

More From Other Websites
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees Mar 17 2017
Exact Sciences to participate in March investor conferences Mar 03 2017
Exact Sciences and Mayo Clinic study shows promise of new blood-based lung cancer test Mar 01 2017
Fight Colorectal Cancer and Exact Sciences Corp. (Nasdaq: EXAS) to Ring The Nasdaq Stock Market... Feb 28 2017
EXACT SCIENCES CORP Financials Feb 25 2017
Pfizer's Leukemia Candidate Gets Priority Review in U.S. Feb 22 2017
Is EXAS Getting Ahead of Itself? Feb 22 2017
EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017 Feb 22 2017
[$$] Exact Sciences Is on Target for More Gains Feb 22 2017
EXACT Sciences upgraded by ROTH Capital Feb 22 2017
Edited Transcript of EXAS earnings conference call or presentation 21-Feb-17 3:00pm GMT Feb 21 2017
EXACT SCIENCES CORP Files SEC form 10-K, Annual Report Feb 21 2017
​Exact Sciences revenue jumps 152% as Cologuard use soars Feb 21 2017
Q4 2016 Exact Sciences Corp Earnings Release - Before Market Open Feb 21 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)